BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16174288)

  • 1. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.
    Ha H; Lee HB
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S7-10. PubMed ID: 16174288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 and diabetic nephropathy.
    Lee HB; Ha H
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.
    Lee HB; Yu MR; Yang Y; Jiang Z; Ha H
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S241-5. PubMed ID: 12874439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells.
    Rhyu DY; Park J; Sharma BR; Ha H
    Transplant Proc; 2012 Apr; 44(3):625-8. PubMed ID: 22483454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II.
    Russell ST; Eley H; Tisdale MJ
    Cell Signal; 2007 Aug; 19(8):1797-806. PubMed ID: 17532611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NAD(P)H oxidase in transforming growth factor-beta1-induced monocyte chemoattractant protein-1 and interleukin-6 expression in rat renal tubular epithelial cells.
    Zhang H; Jiang Z; Chang J; Li X; Zhu H; Lan HY; Zhou SF; Yu X
    Nephrology (Carlton); 2009 Apr; 14(3):302-10. PubMed ID: 19207862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy.
    Ha H; Hwang IA; Park JH; Lee HB
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S42-5. PubMed ID: 18845352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
    Wolf G
    Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
    Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species and matrix remodeling in diabetic kidney.
    Ha H; Lee HB
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S246-9. PubMed ID: 12874440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
    Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
    Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
    Koike N; Takamura T; Kaneko S
    Life Sci; 2007 Apr; 80(18):1721-8. PubMed ID: 17346751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
    Park J; Ryu DR; Li JJ; Jung DS; Kwak SJ; Lee SH; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim K; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F749-57. PubMed ID: 18579703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
    Wei J; Shi Y; Hou Y; Ren Y; Du C; Zhang L; Li Y; Duan H
    Cell Signal; 2013 Dec; 25(12):2788-96. PubMed ID: 24041652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.